LC-MS Orbitrap-based metabolomics using a novel hybrid zwitterionic hydrophilic interaction liquid chromatography and rigorous metabolite identification reveals doxorubicin-induced metabolic perturbations in breast cancer cells.

Documenti analoghi

• LC-MS-based metabolomics revealed promising role of leukotriene receptor antagonists against colorectal cancer.
  di: Hudaib, Farah, et al.
  Pubblicazione: (2025)
• Integrating untargeted and targeted LC–MS‐based metabolomics to identify the serum metabolite biomarkers for tuberculosis
  di: Yuping Sa, et al.
  Pubblicazione: (2024)
• Figure 5 from: Nimer RM, Nazazleh HA, Al-Husein BA, Abdelrazig S, Elsalem L, Dahabiyeh LA (2025) LC-MS/MS-based proteomics and metabolomics of HCT-116 colorectal cancer cells: A potential anticancer activity of atorvastatin. Pharmacia 72: 1-13. https://doi.org/10.3897/pharmacia.72.e138515
  di: Nimer, Refat M., et al.
  Pubblicazione: (2025)
• Metabolic Profiling of Sitravatinib in Rat and Human Liver Microsomes Using LC–MS/MS and LC–Orbitrap–HRMS
  di: Shan Xu, et al.
  Pubblicazione: (2025)
• CoreMS tools workflow for LC-Orbitrap-MS analysis of STING SGD and river samples
  di: Boiteau, Rene, et al.
  Pubblicazione: (2026)